MAP2K7 and melanoma: Recently, BRAF mutant melanoma samples were distinguished from BRAF wild-type samples [123], suggesting that gene expression profiling according to BRAF status might be useful for the identification of molecular markers involved in RAS-RAS-MEK-ERK-MAPK signalling.